Comparison of efficacy and safety between gatifloxacin and levofloxacin in treatment of patients with light to moderate acute lower respiratory tract infections
- VernacularTitle:加替沙星片与左氧氟沙星片治疗轻中度急性下呼吸道感染的临床疗效比较
- Author:
Ying WANG
- Publication Type:Journal Article
- Keywords:
pharmacodynamics;
gatifloxacin;
levofloxacin;
randomized controlled trial;
acute lower respiratory tract infections
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
1999;0(04):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05 ), bacterial clearance were 100% and 90%, and adverse reaction rates were 10%(2/20)and 10.53 % ( 2/19 ), respectively. All those adverse reactions were mainly gastrointestinal tract reactions. The abnormality of laboratory inspections associated with trial drugs happened to 4 and 5 patients in two groups. The reactions were mostly light increase of aminotransferase without effect on therapy. CONCLUSION: Gatifloxacin is an antibiotic with large antimicrobial spectrum and can be recommended to treat light to moderate acute lower respiratory tract infections.
